Clinical trial Recruiting at 1 site Observational Ages 18 and up

Graft function after autologous islet transplantation

Official title: Analysis of Graft Function Following Autologous Islet Transplantation

Run by Baylor Research Institute · NCT03097185 · Data updated 2026-11-12

We will see if measuring inflammatory markers in blood before and after total pancreatectomy with islet autotransplantation helps explain how well transplanted islet cells work in adults with chronic pancreatitis.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorBaylor Research Institute
Academic / other
Locations1 site (Dallas, Texas)
StatusRecruiting
StartedJune 3, 2010
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedDecember 8, 2025
Trial IDNCT03097185 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with chronic pancreatitis who are scheduled for total pancreatectomy with or without islet autotransplantation and who can attend follow-up visits at Baylor are ideal candidates.

Probably not a fit

Patients who cannot attend required follow-up visits at Baylor or those with very advanced pancreatitis who are not suitable for TP-AIT are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll 100 adults with chronic pancreatitis who are scheduled for total pancreatectomy with islet autotransplantation (TP-AIT) or total pancreatectomy (TP) alone at Baylor centers. Blood samples will be collected serially to measure inflammatory markers and blood-based indicators of islet graft function such as C-peptide and glucose control. The cohort includes up to 85 TP-AIT and 15 TP-alone participants and may include patients concurrently enrolled in a reparixin interventional protocol. Data will be analyzed to correlate perioperative inflammation with subsequent islet graft performance.

Why it matters

Potential benefit: If successful, the findings could help predict which patients will retain insulin-producing function after TP-AIT and guide personalized perioperative care.

How similar studies have gone: Previous observational work has linked inflammatory markers to islet transplant outcomes, but prospective biomarker profiling specifically around TP-AIT remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with chronic pancreatitis and who are scheduled for TP alone or TP-AIT
2. Patients aged 18 or older
3. Patients are able and willing to attend required follow-up visits at Baylor

Exclusion Criteria:

1. Patients who are unable/unwilling to attend follow-up visits at Baylor
2. For TP-AIT subjects: Patients who have advanced stage of chronic pancreatitis. The principal investigator or co-investigators carefully review the medical charts, laboratory results and radiology department reports and determine the suitability for this study.

Where it's running

  • Baylor University Medical Center - Sammons Outpatient Cancer Center
    Dallas, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Ernest E Beecherl, MD — Sammons Cancer Center, Baylor University Medical Center
  • Study coordinator: Anne M Jones, BSN, RN
  • Email: anne.jones@bswhealth.org
  • Phone: 214-820-7623

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.